Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXPH9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,137
Award facts
- Contract value 100% obligated
- $13,137.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,137.40 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit of use packaging) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's portfolio of federal contract awards demonstrates extensive experience fulfilling pharmaceutical procurement across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. As DLA Troop Support prepares to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, AmerisourceBergen maintains a significant position as a strategic supplier to federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FXPH9?
SPE2DR26FXPH9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FXPH9 worth?
The government has obligated $13,137 on SPE2DR26FXPH9.
Is contract SPE2DR26FXPH9 an order under another contract?
Yes. SPE2DR26FXPH9 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXPH9 competed?
The extent of competition for SPE2DR26FXPH9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award